That was long I 'm winded.
One thing I was thinking about was patients who switched to
expensive biologics like Humira because they couldn't handle oral
methotrexate. Will they switch back to the gold standard of treatment?
Folks are frustrated with the stock price and they see other unprofitable bios going up 100%, throw in selling every month of insiders.
That's the beauty of holding ATRS
The risk / reward factor , not much downside
unless O flop. This hasn't run up like other bios.
Excellent post Rearview
I understand both sides of the argument and can go either way,
but in 6 months or so we should know if this is worth holding onto.
Doesn't he read the YMB
Look at the short interest , this baby is going to $8 next year.
What could be possibly need ? Grocery money , a new Garmin.
The oddsmakers are no dummies. If they put a big number up
everyone bets FSU,the small number will draw bets from both sides.
It will be interesting to see where early money goes the Wiseguys
get it right more times than not.
I have a Question
What about the trademark for Otrexup ?
Why couldn't they start sales after FDA approval in October ?